Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored

被引：13
|
作者：
Castinetti, Frederic [1 ]
Amodru, Vincent [1 ]
Brue, Thierry [1 ]
机构：
[1] Aix Marseille Univ, La Conception Hosp, AP HM, INSERM,MMG,Marmara Inst,Dept Endocrinol, Marseille, France
来源：
CLINICAL ENDOCRINOLOGY | 2023年 / 98卷 / 04期
关键词：
Adrenal; adrenal insufficiency; cortisol; Cushing's disease; Pituitary; steroidogenesis inhibitor; 11-BETA-HYDROXYLASE INHIBITOR; MULTICENTER; EFFICACY; SAFETY;
D O I：
10.1111/cen.14551
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Antisecretory data shows a highly effective and prolonged blockade of cortisol secretion with osilodrostat. The drawback is the occurrence of adrenal insufficiency (AI) in roughly a quarter of treated patients. In this short manuscript, we report three cases of atypical adrenal insufficiency with osilodrostat.
引用
收藏
页码：629 / 630
页数：2
相关论文
共 50 条
  • [1] Osilodrostat-induced adrenal insufficiency in a patient with Cushing's disease
    Ekladios, Catherine
    Khoury, Jessica
    Mehr, Shahzad
    Feghali, Krystel
    CLINICAL CASE REPORTS, 2022, 10 (11):
  • [2] Osilodrostat (Isturisa) for Cushing's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1617): : 21 - 23
  • [3] Response to Osilodrostat Therapy in Adrenal Cushing's Syndrome
    Stasiak, Magdalena
    Witek, Przemyslaw
    Adamska-Fita, Emilia
    Lewinski, Andrzej
    DRUG HEALTHCARE AND PATIENT SAFETY, 2024, 16 : 35 - 42
  • [4] Osilodrostat for the treatment of Cushing's disease
    Rasool, Syeda
    Skinner, Brian W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (09) : 1099 - 1106
  • [5] Adrenal Cushing ' s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
    Malik, Risha B.
    Ben-Shlomo, Anat
    AACE CLINICAL CASE REPORTS, 2022, 8 (06): : 267 - 270
  • [6] Osilodrostat oral tablets for adults with Cushing's disease
    Martino, Marianna
    Aboud, Nairus
    Lucchetti, Beatrice
    Salvio, Gianmaria
    Arnaldi, Giorgio
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (02) : 99 - 109
  • [7] Osilodrostat: A Novel Steroidogenesis Inhibitor to Treat Cushing's Disease
    Dougherty, John A.
    Desai, Divya Sanjaykumar
    Herrera, Javier Barrios
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (08) : 1050 - 1060
  • [8] Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence
    Chabre, Olivier
    Muller, Marie
    Cristante, Justine
    Cracowski, Jean-Luc
    Gay, Emmanuel
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (06): : 384 - 385
  • [9] Osilodrostat: 11β-hydroxylase inhibitor for treatment of Cushing's disease
    Paton, D. M.
    DRUGS OF TODAY, 2020, 56 (10) : 643 - 654
  • [10] Cushing's syndrome and adrenal insufficiency in pregnancy
    Bertherat, J
    Billaud, L
    Guilhaume, B
    ANNALES D ENDOCRINOLOGIE, 2002, 63 (05) : 452 - 456
12345